Wednesday, August 31, 2016

EpiPen Suffers At The Stock Market
Karma struck back against the makers of EpiPen, as stock prices plummeted. When word got out that the Clinton campaign got the windfall profits from EpiPen, stockholders went into a sell frenzy, sinking the stock prices.Let them all choke!

posted from Bloggeroid

blog comments powered by Disqus